Does TEBENTAFUSP Cause Malignant neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Malignant neoplasm progression have been filed in association with TEBENTAFUSP (KIMMTRAK). This represents 18.4% of all adverse event reports for TEBENTAFUSP.
18
Reports of Malignant neoplasm progression with TEBENTAFUSP
18.4%
of all TEBENTAFUSP reports
4
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TEBENTAFUSP?
Of the 18 reports, 4 (22.2%) resulted in death, 7 (38.9%) required hospitalization, and 3 (16.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEBENTAFUSP. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TEBENTAFUSP Cause?
Cytokine release syndrome (35)
Pyrexia (19)
Disease progression (11)
Pruritus (10)
Rash (9)
Chills (8)
Hypotension (8)
Death (7)
Vomiting (7)
Diarrhoea (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)